Novel heterozygous TREX1 mutation in a juvenile systemic lupus erythematosus patient with severe cutaneous involvement treated successfully with Jak-inhibitors: a case report.

MLA

Rossano, Martina, et al. “Novel Heterozygous TREX1 Mutation in a Juvenile Systemic Lupus Erythematosus Patient with Severe Cutaneous Involvement Treated Successfully with Jak-Inhibitors: A Case Report.” Frontiers in Immunology, vol. 14, Dec. 2023, p. 1288675. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1288675.

APA

Rossano, M., Conti, E. A., Bocca, P., Volpi, S., Mastrangelo, A., Cavalli, R., Gattorno, M., Minoia, F., & Filocamo, G. (2023). Novel heterozygous TREX1 mutation in a juvenile systemic lupus erythematosus patient with severe cutaneous involvement treated successfully with Jak-inhibitors: a case report. Frontiers in Immunology, 14, 1288675. https://doi.org/10.3389/fimmu.2023.1288675

Chicago

Rossano, Martina, Emilio Amleto Conti, Paola Bocca, Stefano Volpi, Antonio Mastrangelo, Riccardo Cavalli, Marco Gattorno, Francesca Minoia, and Giovanni Filocamo. 2023. “Novel Heterozygous TREX1 Mutation in a Juvenile Systemic Lupus Erythematosus Patient with Severe Cutaneous Involvement Treated Successfully with Jak-Inhibitors: A Case Report.” Frontiers in Immunology 14 (December): 1288675. doi:10.3389/fimmu.2023.1288675.